Epidiolex passes another clinical trial for treatment of Dravet syndrome

Results from a successful phase three clinical trial on the use of Epidiolex to treat drug-resistant Dravet syndrome have been published in the JAMA Neurology journal ...

Restricted content. Do you want to read more?